Michael Rand, Pharm D, MBA
About Michael Rand, Pharm D, MBA
Michael Rand, Pharm D, MBA, is a Sr. Medical Science Liaison specializing in Dermatology and Immunology at Bristol Myers Squibb, focusing on deucravacitinib. He has extensive experience in the pharmaceutical industry, including roles at Gilead Sciences, Dermira, Inc., and Amgen.
Professional Experience at Bristol Myers Squibb
Michael Rand currently holds the position of Sr. Medical Science Liaison, Dermatology / Immunology - Deucravacitinib at Bristol Myers Squibb in Philadelphia, Pennsylvania. He started this role on January 1, 2021. Michael's responsibilities include developing and maintaining relationships with thought leaders in dermatology. His territory includes regions such as Philadelphia, Delaware, Maryland, and Washington D.C., where he focuses on the drug deucravacitinib.
Previous Roles and Experience
Before joining Bristol Myers Squibb, Michael Rand held various roles in the pharmaceutical industry. He worked at Gilead Sciences as Principal Medical Scientist for 6 months in 2020-2021 and at Dermira, Inc. as Regional Scientific Director for 7 months in 2019-2020, both in the Greater Philadelphia Area. Earlier, he held positions at Indivior, AstraZeneca, Amgen, and Novartis, where he gained extensive experience in medical science liaison and regional scientific roles. Notably, he began his industry career at TAP Pharmaceuticals as Clinical Marketing Manager from 2000 to 2001.
Education Background in Pharmacy and Business Administration
Michael Rand holds advanced degrees in both pharmacy and business administration. He graduated from Temple University School of Pharmacy with a PharmD degree, followed by a Bachelor of Science in Pharmacy from the same institution. He further advanced his education by achieving an MBA from the Fox School of Business at Temple University, where he specialized in marketing.
Expertise in Dermatology and Immunology
Throughout his career, Michael Rand has specialized in dermatology and immunology. His current role at Bristol Myers Squibb involves focusing on the drug deucravacitinib, specifically addressing dermatological and immunological conditions. His extensive background and ongoing efforts have positioned him as a key figure in these specific medical fields.
Roles in Dermatology and Immunology
Michael Rand has accumulated considerable experience in dermatology and immunology through various professional roles. After achieving his academic credentials, he served as a Senior Regional Medical Liaison at Amgen, later moving to AstraZeneca and Indivior in regional scientific and medical roles. His career progression emphasizes his long-standing focus on dermatology and immunology, culminating in his current work with deucravacitinib at Bristol Myers Squibb.